Drugs / Budecort Aqua
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01022047 Comparator | Feb 2010 | allergic rhinitis | Eurofarma Laboratorios S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Budecort Aqua | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01022047 ↗ |
| Route | Intranasal | “one application in each nostril” NCT01022047 ↗ |